Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
NCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 06923761 Brief Summary This is a Phase I/II, open-label, first-in human…
Read more arrow_forwardNCT 06554795 Brief Summary A Phase 1/2a First-in-Human Study of DB-1419 in…
Read more arrow_forwardNCT 05277051 Brief Summary This is a first time in-human (FTIH) study…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forward